The human endocannabinoid system (ECS) is a biological system present in all mammals and plays a crucial role in managing various biological processes, including memory, sleep, immune response, and more.

The ECS primarily consists of two types of cannabinoid receptors, CB1 and CB2. These receptors are designed to interact with endocannabinoids, which are cannabinoids naturally produced by the brain. They can also interact with plant-derived cannabinoids, leading to various responses throughout the body.

Cannabinoids have shown potential for a wide range of therapeutic uses, including antioxidant, neuroprotective, anti-inflammatory, pain-relieving, anti-tumor, sleep-modulating, anti-psychotic, and anti-anxiety effects.

The most well-known cannabinoid, delta-9-tetrahydrocannabinol (THC), is responsible for the “high” associated with cannabis and can influence perception, mood, emotion, cognition, and motor function. Other cannabinoids, such as cannabidiol (CBD), are non-psychoactive but have significant medicinal properties.